Healthcare Research & Analytics® Explored What is Most Important to Oncology Patients and Caregivers
Cranbury, NJ (PRWEB) March 02, 2017 -- Healthcare Research & Analytics® (HRA®) collaborated with Cure Media Group to survey more than 4,000 oncology patients and determine what was most important during their treatment. These results all pointed to the concept of ‘Compassionate Care.’ Today at 2 p.m. EST, HRA® will host a 45-minute webinar, “Defining Compassionate Care Through the Voices of Patients and Advocates,” that will unveil some of the findings and implications of this syndicated study.
This webinar will expand understanding on what patients and their caregivers appreciate from treatment centers which will allow the centers to better craft messaging as well as treatment options for patient-centric approaches. Additionally, the results will benefit institutions and ultimately assist in producing better patient outcomes in the oncology space.
To register for the webinar, click here: https://event.webcasts.com/starthere.jsp?ei=1133128. If you cannot attend, but would like to, please register with the link above to watch the webinar on-demand at your convenience.
About HRA®:
HRA® – Healthcare Research & Analytics® is a consultative health care market research practice leveraging a flexible spectrum of solutions to support decision-making and strategy development across health care channels with expertise in the hospital setting, and specializations in managed markets, oncology, and pharmacy. HRA®’s team of highly experienced market researchers combines deep domain expertise in health care, science, technology, and statistics with a passion for uncovering insights. HRA®’s portfolio of offerings encompasses technology-driven quantitative and qualitative, custom and syndicated market research services to support the business needs of the pharmaceutical, biotech, and medical device markets. HRA®’s people and its products provide the health care market with actionable intelligence — facilitating better business decisions. For more information, visit http://www.hraresearch.com.
Theresa Burek, HRA, +1 609-649-0806, [email protected]
Share this article